These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8416798)

  • 1. Relationship of levels and kinetics of H-ras expression to transformed phenotype and loss of TGF-beta 1-mediated growth regulation in intestinal epithelial cells.
    Zhao J; Buick RN
    Exp Cell Res; 1993 Jan; 204(1):82-7. PubMed ID: 8416798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
    Zhao J; Buick RN
    Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGF-beta 1) and alters the number and type of TGF-beta 1 receptors in rat intestinal epithelial cell clones.
    Filmus J; Zhao J; Buick RN
    Oncogene; 1992 Mar; 7(3):521-6. PubMed ID: 1312703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
    Serra R; Verderame MF; Isom HC
    Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transforming growth factor alpha (TGF-alpha) in the transformation of ras-transfected rat intestinal epithelial cells.
    Filmus J; Shi W; Spencer T
    Oncogene; 1993 Apr; 8(4):1017-22. PubMed ID: 8455929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 suppresses transformation in hepatocytes by regulating alpha 1 beta 1 integrin expression.
    Serra R; Carbonetto S; Lord M; Isom HC
    Cell Growth Differ; 1994 May; 5(5):509-17. PubMed ID: 8049157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.
    Huber BE; Cordingley MG
    Oncogene; 1988 Sep; 3(3):245-56. PubMed ID: 3060790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
    Valverius EM; Walker-Jones D; Bates SE; Stampfer MR; Clark R; McCormick F; Dickson RB; Lippman ME
    Cancer Res; 1989 Nov; 49(22):6269-74. PubMed ID: 2553252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
    Lo J; Hurta RA
    Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells.
    Kim ES; Kim MS; Moon A
    Cytokine; 2005 Jan; 29(2):84-91. PubMed ID: 15598443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of epithelial membrane antigen expression by transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
    Walker-Jones D; Valverius EM; Stampfer MR; Lippman ME; Dickson RB
    Cancer Res; 1989 Nov; 49(22):6407-11. PubMed ID: 2680064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.
    Haddow S; Fowlis DJ; Parkinson K; Akhurst RJ; Balmain A
    Oncogene; 1991 Aug; 6(8):1465-70. PubMed ID: 1886717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
    Hurta RA; Wright JA
    J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of transforming growth factor beta on rat hepatocyte cell lines depends upon the state of tumorigenic progression.
    Reeder MK; Isom HC
    Cell Growth Differ; 1996 Apr; 7(4):449-60. PubMed ID: 9052986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.